Protagenic Therapeutics Successfully Concludes Third Cohort in Single Dose Portion of Phase 1 Trial for Stress-Related Neuropsychiatric Disorders
Yahoo FinanceMar 27 08:42 ET
Protagenic Therapeutics Schedules First Q4 and FY 2023 Earnings Call
Yahoo FinanceMar 25 17:00 ET
Protagenic Therapeutics Announces Resolution of Nasdaq Deficiency Notice
Yahoo FinanceMar 21 08:41 ET
No Data
No Data